Quest Diagnostics Incorporated
US ˙ NYSE ˙ US74834L1008

SecurityDGX / Quest Diagnostics Incorporated
InstitutionJJJ Advisors Inc.
Latest Disclosed Ownership89 shares
Latest Disclosed Value $ 12,183
JJJ Advisors Inc. reports 5.32% decrease in ownership of DGX / Quest Diagnostics Incorporated

On July 25, 2024 - JJJ Advisors Inc. filed a 13F-HR form disclosing ownership of 89 shares of Quest Diagnostics Incorporated (US:DGX) valued at $12,182 USD as of June 30, 2024. The entity filed a previous 13F-HR on April 15, 2024 disclosing 94 shares of Quest Diagnostics Incorporated. This represents a change in shares of -5.32% during the quarter. The current value of the position is $17,826 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2024-07-25 2024-06-30 13F QUEST DIAGNOSTICS COM 74834L100 89 -5 -5.32 12 0.00 0.0026
2024-04-15 2024-03-31 13F QUEST DIAGNOSTICS COM 74834L100 94 -2 -2.08 13 -7.69 0.0027
2024-01-29 2023-12-31 13F QUEST DIAGNOSTICS COM 74834L100 96 -3 -3.03 13 8.33 0.0032
2023-10-13 2023-09-30 13F QUEST DIAGNOSTICS COM 74834L100 99 3 3.12 12 -7.69 0.0032
2023-07-11 2023-06-30 13F QUEST DIAGNOSTICS COM 74834L100 96 -1 -1.03 13 0.00 0.0037
2023-04-21 2023-03-31 13F QUEST DIAGNOSTICS COM 74834L100 97 0 0.00 14 -7.14 0.0039
2023-01-23 2022-12-31 13F QUEST DIAGNOSTICS COM 74834L100 97 1 1.04 14 16.67 0.0040
2022-10-17 2022-09-30 13F QUEST DIAGNOSTICS COM 74834L100 96 -114 -54.29 12 -58.62 0.0039
2022-08-03 2022-06-30 13F QUEST DIAGNOSTICS COM 74834L100 210 -50 -19.23 29 -19.44 0.0086
2022-05-05 2022-03-31 13F QUEST DIAGNOSTICS COM 74834L100 260 -26 -9.09 36 -26.53 0.0099
2022-02-02 2021-12-31 13F QUEST DIAGNOSTICS COM 74834L100 286 -7 -2.39 49 13.95 0.0147
2021-10-25 2021-09-30 13F/A-1 QUEST DIAGNOSTICS COM 74834L100 293 9 3.17 43 16.22 0.0152
2021-10-19 2021-09-30 13F QUEST DIAGNOSTICS COM 74834L100 293 9 43 0.0151
2021-07-28 2021-06-30 13F QUEST DIAGNOSTICS COM 74834L100 284 94 49.47 37 54.17 0.0134
2021-04-28 2021-03-31 13F QUEST DIAGNOSTICS COM 74834L100 190 146 331.82 24 380.00 0.0096
2021-01-26 2020-12-31 13F QUEST DIAGNOSTICS COM 74834L100 44 35 388.89 5 400.00 0.0024
2020-10-19 2020-09-30 13F QUEST DIAGNOSTICS COM 74834L100 9 9 1 0.0005
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.